IF YOU PURCHASED THE PRESCRIPTION DRUGS THALOMID OR REVLIMID, YOUR RIGHTS MAY BE AFFECTED, AND YOU COULD GET A PAYMENT FROM A CLASS ACTION SETTLEMENT.
A settlement has been reached with Celgene Corporation ("Celgene") in a class action lawsuit about whether it acted to keep generic versions of Thalomid and Revlimid off the market. You may be a Settlement Class Member if you are:
Celgene has agreed to settle the lawsuit for $55 million.
You may be included in this settlement if you are a Third Party Payor or consumer that paid for all or some of the purchase price of Thalomid or Revlimid in California, the District of Columbia, Florida, Kansas, Maine, Massachusetts, Michigan, Nebraska, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, or Tennessee any time before August 1, 2019.
|YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT:|
SUBMIT A CLAIM FORM:
DEADLINE: December 30, 2019
|This is the only way you can receive any payment from the settlement with Celgene.|
|EXCLUSION DEADLINE: December 2, 2019||
If you decide to exclude yourself or your entity, you will keep the right to sue Celgene in a separate lawsuit about the claims this settlement resolves, but you give up the right to get a payment from this settlement.
This is the only option that allows you to sue, continue to sue, or be part of another lawsuit against Celgene related to the legal claims in this case.
|OBJECTION DEADLINE: December 2, 2019||If you want to remain a Settlement Class Member, you may object to it by writing to the Court about why you don't like the settlement.|
|FAIRNESS HEARING: January 6, 2020||If you object to the settlement. you can ask the court to speak at the Fairness Hearing about your objection.|
|DO NOTHING||If you are a Settlement Class Member and you do nothing, you will not receive a payment from the settlement and you will give up the right to sue, continue to sue, or be part of another lawsuit against Celgene for any claim made in this lawsuit or released by the Settlement Agreement.|
Your rights are affected whether you act or do not act. Therefore, you should read the Notice carefully.